Question 1

What is the catalog number for HRP*Anti Human Ig KAPPA?

Accepted Answer

The catalog number for HRP*Anti Human Ig KAPPA is MBS9526071.

Question 2

What sizes are available for HRP*Anti Human Ig KAPPA?

Accepted Answer

HRP*Anti Human Ig KAPPA is available in the following size(s): 0.1 mL, 5x 0.1 mL.

Question 3

How many pack sizes does HRP*Anti Human Ig KAPPA come in?

Accepted Answer

HRP*Anti Human Ig KAPPA is available in 2 different pack sizes.

Question 4

Is HRP*Anti Human Ig KAPPA in stock?

Accepted Answer

HRP*Anti Human Ig KAPPA is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 6

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 7

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

HRP*Anti Human Ig KAPPA

Product Specifications

Gene Name

Reactivity

Storage Conditions

Short Name

Available Sizes

Frequently Asked Questions

Explore Other Products

Cytokeratin 8/18 (C-51), CF568 conjugate, 0.1mg/mL

Cytokeratin 8/18 (C-51), CF488A conjugate, 0.1mg/mL

MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF740 conjugate, 0.1mg/mL

CD47 (B6H12.2), CF405S conjugate, 0.1mg/mL

Cytokeratin 5/8 (C-50), CF405S conjugate, 0.1mg/mL

Renal Cell Carcinoma (Carbonic Anhydrase IX) (66.4.C2), CF740 conjugate, 0.1mg/mL